Factors predicting the instant effect of motor function after subthalamic nucleus deep brain stimulation in Parkinson’s disease

[1]  Houeto Jean-Luc.  [Parkinson's disease]. , 2022, La Revue du praticien.

[2]  S. Chiou,et al.  One-year Outcome of Bilateral Subthalamic Stimulation in Parkinson Disease: An Eastern Experience. , 2015, World neurosurgery.

[3]  Z. Pei,et al.  Long-term Efficacy of Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease: A 5-year Follow-up Study in China , 2015, Chinese medical journal.

[4]  Changwei Liu,et al.  Contrast-enhanced Ultrasound in Detecting Endoleaks with Failed Computed Tomography Angiography Diagnosis after Endovascular Abdominal Aortic Aneurysm Repair , 2015, Chinese medical journal.

[5]  M. Rizzone,et al.  Earlier versus later subthalamic deep brain stimulation in Parkinson's disease. , 2015, Parkinsonism & related disorders.

[6]  Y. Li,et al.  Long-term follow-up of bilateral subthalamic nucleus stimulation in Chinese Parkinson's disease patients , 2015, British journal of neurosurgery.

[7]  B. Bloem,et al.  Axial disability and deep brain stimulation in patients with Parkinson disease , 2015, Nature Reviews Neurology.

[8]  P. Pollak,et al.  Subthalamic nucleus‐deep brain stimulation for early motor complications in Parkinson's disease—the EARLYSTIM trial: Early is not always better , 2014, Movement disorders : official journal of the Movement Disorder Society.

[9]  Y. Sohn,et al.  Factors Related to Outcomes of Subthalamic Deep Brain Stimulation in Parkinson's Disease , 2013, Journal of Korean Neurosurgical Society.

[10]  G. Shukla,et al.  A case control study of women with Parkinson's disease and their fertility characteristics , 2012, Journal of the Neurological Sciences.

[11]  J. Ferreira,et al.  Late-stage Parkinson disease , 2012, Nature Reviews Neurology.

[12]  F. Horak,et al.  Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues. , 2011, Archives of neurology.

[13]  C. Clarke,et al.  Systematic review of levodopa dose equivalency reporting in Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.

[14]  L. Defebvre,et al.  Dopaminergic and non‐dopaminergic pharmacological hypotheses for gait disorders in Parkinson’s disease , 2010, Fundamental & clinical pharmacology.

[15]  D. Berg,et al.  Progression of Parkinson's disease in the clinical phase: potential markers , 2009, The Lancet Neurology.

[16]  Sheng-Huang Lin,et al.  Prognostic Factors of Subthalamic Stimulation in Parkinson’s Disease: A Comparative Study between Short- and Long-Term Effects , 2009, Stereotactic and Functional Neurosurgery.

[17]  L. Defebvre,et al.  Exhaustive, one-year follow-up of subthalamic nucleus deep brain stimulation in a large, single-center cohort of parkinsonian patients. , 2007, Neurosurgery.

[18]  J. Volkmann,et al.  Basic algorithms for the programming of deep brain stimulation in Parkinson's disease , 2006, Movement disorders : official journal of the Movement Disorder Society.

[19]  G. Deuschl,et al.  Subthalamic nucleus deep brain stimulation: Summary and meta‐analysis of outcomes , 2006, Movement disorders : official journal of the Movement Disorder Society.

[20]  V. Henderson.  The Neurology of Menopause , 2006, The neurologist.

[21]  D. Dexter,et al.  Sex dimorphisms in the neuroprotective effects of estrogen in an animal model of Parkinson's disease , 2004, Pharmacology Biochemistry and Behavior.

[22]  E. Montgomery.  Predictors of effective bilateral subthalamic nucleus stimulation for PD , 2003, Neurology.

[23]  A. Benabid,et al.  Predictors of effective bilateral subthalamic nucleus stimulation for PD , 2002, Neurology.

[24]  M Zappia,et al.  Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease , 2001, Movement disorders : official journal of the Movement Disorder Society.

[25]  R. Roth,et al.  Estrogen Is Essential for Maintaining Nigrostriatal Dopamine Neurons in Primates: Implications for Parkinson's Disease and Memory , 2000, The Journal of Neuroscience.

[26]  Y. Agid,et al.  Axial parkinsonian symptoms can be improved: the role of levodopa and bilateral subthalamic stimulation , 2000, Journal of neurology, neurosurgery, and psychiatry.

[27]  A. Benabid,et al.  Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. , 1998, The New England journal of medicine.

[28]  A. Lang,et al.  Parkinson's disease. First of two parts. , 1998, The New England journal of medicine.

[29]  D. Dluzen,et al.  Estrogen Alters MPTP‐Induced Neurotoxicity in Female Mice: Effects on Striatal Dopamine Concentrations and Release , 1996, Journal of neurochemistry.

[30]  J. Hughes,et al.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[31]  J. Jankovic,et al.  Variable expression of Parkinson's disease , 1990, Neurology.

[32]  G. Liang,et al.  Effect of Subthalamic Nuclei Electrical Stimulation in the Treatment of Parkinson’s Disease , 2014, Cell Biochemistry and Biophysics.

[33]  G. Deuschl,et al.  Stimulation of the subthalamic nucleus at an earlier disease stage of Parkinson's disease: concept and standards of the EARLYSTIM-study. , 2013, Parkinsonism & related disorders.

[34]  P. Riederer,et al.  Animal models of Parkinson's disease: An empirical comparison with the phenomenology of the disease in man , 2005, Journal of Neural Transmission.

[35]  D. Brooks,et al.  Core assessment program for intracerebral transplantations (CAPIT) , 1992, Movement disorders : official journal of the Movement Disorder Society.